TY - JOUR
T1 - Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease
AU - Sato, Kaori
AU - Eizumi, Kawori
AU - Fukaya, Tomohiro
AU - Fujita, Shigeharu
AU - Sato, Yumiko
AU - Takagi, Hideaki
AU - Yamamoto, Mai
AU - Yamashita, Naohide
AU - Hijikata, Atsushi
AU - Kitamura, Hiroshi
AU - Ohara, Osamu
AU - Yamasaki, Sho
AU - Saito, Takashi
AU - Sato, Katsuaki
PY - 2009
Y1 - 2009
N2 - Chronic graft-versus-host disease (cGVHD) is a limiting factor in allogeneic hematopoietic stem cell transplantation (alloHSCT) for the treatment of leukemia and other malignancies. Relative to the process that initiates and promotes cGVHD, the regulation is poorly understood. In this study, we examined the role of naturally occurring regulatory dendritic cells (DCregs) in murine major histocompatibility complex (MHC)-compatible and multiple minor histocompatibility antigen (miHAg)-incompatible model of cGVHD in alloHSCT. DCregs generated from bone marrow in vitro (BM-DCregs) exclusively expressed CD200 receptor 3 (CD200R3), which exerted a suppressive function in the Ag-specific CD4+ T-cell response. CD49+ CD200R3+ cells showed similarities in phenotype and function to BM-DCregs, which formally distinguishes them from other leukocytes, suggesting that they are the natural counterpart of BM-DCregs. Treatment of the recipient mice after alloHSCT with the recipient-type CD49 + CD200R3+ cells as well as BM-DCregs protected against cGVHD, and the protection was associated with the generation of Ag-specific anergic CD4+ T cells as well as CD4+CD25 +Foxp3+ regulatory T cells (Tregs) from donor-derived alloreactive CD4+CD25-Foxp3- T cells. In addition, the depletion of CD49+CD200R3+ cells before alloHSCT enhanced the progression of cGVHD. In conclusion, CD49 + CD200R3+ cells act as naturally occurring D Cregs to regulate the pathogenesis of cGVHD in alloHSCT mediated through the control of the transplanted alloreactive CD4+ T cells.
AB - Chronic graft-versus-host disease (cGVHD) is a limiting factor in allogeneic hematopoietic stem cell transplantation (alloHSCT) for the treatment of leukemia and other malignancies. Relative to the process that initiates and promotes cGVHD, the regulation is poorly understood. In this study, we examined the role of naturally occurring regulatory dendritic cells (DCregs) in murine major histocompatibility complex (MHC)-compatible and multiple minor histocompatibility antigen (miHAg)-incompatible model of cGVHD in alloHSCT. DCregs generated from bone marrow in vitro (BM-DCregs) exclusively expressed CD200 receptor 3 (CD200R3), which exerted a suppressive function in the Ag-specific CD4+ T-cell response. CD49+ CD200R3+ cells showed similarities in phenotype and function to BM-DCregs, which formally distinguishes them from other leukocytes, suggesting that they are the natural counterpart of BM-DCregs. Treatment of the recipient mice after alloHSCT with the recipient-type CD49 + CD200R3+ cells as well as BM-DCregs protected against cGVHD, and the protection was associated with the generation of Ag-specific anergic CD4+ T cells as well as CD4+CD25 +Foxp3+ regulatory T cells (Tregs) from donor-derived alloreactive CD4+CD25-Foxp3- T cells. In addition, the depletion of CD49+CD200R3+ cells before alloHSCT enhanced the progression of cGVHD. In conclusion, CD49 + CD200R3+ cells act as naturally occurring D Cregs to regulate the pathogenesis of cGVHD in alloHSCT mediated through the control of the transplanted alloreactive CD4+ T cells.
UR - http://www.scopus.com/inward/record.url?scp=66549099747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66549099747&partnerID=8YFLogxK
U2 - 10.1182/blood-2008-10-183145
DO - 10.1182/blood-2008-10-183145
M3 - Article
C2 - 19228924
AN - SCOPUS:66549099747
SN - 0006-4971
VL - 113
SP - 4780
EP - 4789
JO - Blood
JF - Blood
IS - 19
ER -